Loading interface...

MyHep LVIR Tablet

Manufactured byMylan Pharmaceuticals
ContainsLedipasvir (90 mg) + Sofosbuvir (400 mg)
Description
MyHep LVIR Tablet is a combination medicine used for the treatment of chronic hepatitis C infection. This medicine should be used with extreme caution in patients with a known history of hepatitis B infection due to the increased risk of serious adverse reactions.

Side effects

Major & minor side effects for MyHep LVIR Tablet

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Difficulty in falling asleep
  • Irritability
  • Chest pain
  • Decreased appetite
  • Muscle pain and cramps

Uses of MyHep LVIR Tablet

What is it prescribed for?

  • Chronic Hepatitis C
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to ledipasvir, sofosbuvir or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Hepatitis B

This medicine should be used with extreme caution in patients with a known history of hepatitis B due to the increased risk of reactivation of hepatitis B infection. This may cause serious liver problems including liver failure and death. Screening for hepatitis B prior to beginning treatment, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be done based on the clinical condition.

Use in Children

This medicine is not recommended for use in children below 12 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Carbamazepine

Rifampicin

Fosphenytoin

Digoxin

Amiodarone

Linagliptin

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
It works by stopping the hepatitis C virus from multiplying in the body. This helps in stopping the spread of the infection.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antiviral combinations

Schedule

Schedule H

[Internet]. Dailymed.nlm.nih.gov. 2018 [cited 4 September 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a1c555d-2fdf-4150-8ace-dbc770c226bf

[Internet]. Medicines.org.uk. 2018 [cited 4 September 2018]. Available from:

https://www.medicines.org.uk/emc/product/3461#PHARMACEUTICAL_PARTS

[Internet]. Ebs.tga.gov.au. 2018 [cited 4 September 2018]. Available from:

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2015-PI-01772-1&d=201809041016933
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 2 Aug 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.